| ASSET | YEAR | % RETURN |
|---|---|---|
Galmed Pharmaceuticals (GLMD) | 2014 | -65.88% |
Galmed Pharmaceuticals (GLMD) | 2015 | 30.76% |
Galmed Pharmaceuticals (GLMD) | 2016 | -53.14% |
Galmed Pharmaceuticals (GLMD) | 2017 | 159.94% |
Galmed Pharmaceuticals (GLMD) | 2018 | -25.68% |
Galmed Pharmaceuticals (GLMD) | 2019 | -14.37% |
Galmed Pharmaceuticals (GLMD) | 2020 | -46.19% |
Galmed Pharmaceuticals (GLMD) | 2021 | -42.22% |
Galmed Pharmaceuticals (GLMD) | 2022 | -72.97% |
Galmed Pharmaceuticals (GLMD) | 2023 | -95.49% |
Galmed Pharmaceuticals (GLMD) | 2024 | -40.93% |
Galmed Pharmaceuticals (GLMD) | 2025 | -44.38% |
